CEO SUMMARY: Many of the recently issued reimbursement rates for molecular diagnostic tests are inadequate and in fact are lower than the cost of running the tests, lab experts say. Smaller laboratories that specialize in developing and selling molecular tests could be forced to close. As many as 20 or more molecular labs operate in California […]
Low 2013 Molecular Rates May Bankrupt Some Labs
Prices for some high-volume molecular test fails to cover the lab's cost to perform these tests
- By R. Lewis Dark
- > From the Volume XX No. 2 February 11, 2013 Issue
